Brief: Pharma Equity Q1 Loss At DKK 7.2 Mln
May 16 (Reuters) - Pharma Equity Group A/S PEGRP.CO :
* MAINTAIN PREVIOUSLY ANNOUNCED GUIDANCE FOR 2024
* FOR FIRST 3 MONTHS OF 2024, PHARMA EQUITY GROUP A/S
REALIZED A
LOSS AFTER TAX OF DKK 7.2 MILLION
Source text for Eikon: ID:nGNEc0mXBr
Further company coverage: PEGRP.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations